Health Care
Commentary
Don’t Dam the Telehealth Flood
To say that Americans are anxiously awaiting the end of the COVID-19 pandemic would be an understatement. But for patients who have enjoyed the ease of attending doctor’s appointments virtually, a return to the way things were pre-pandemic might be bittersweet. That’s because onerous restrictions on telemedicine, which lawmakers relaxed ...
Commentary
High Healthcare Spending Doesn’t Bolster Case for Single-Payer
Does the United States spend too much on healthcare? A look at the lower levels of healthcare spending in peer countries like Canada and the United Kingdom would seem to indicate as much. But a closer look at those numbers reveals a far more complex story. Take the matter of ...
Commentary
Plan to Expand Medi-Cal is a Costly Step Towards Single-Payer
It’s budget season in Sacramento. Governor Gavin Newsom’s spending proposal is the largest in the Golden State’s history. There’s no shortage of expensive and misguided policies in his budget. Chief among them is his push to expand Medi-Cal, the state’s Medicaid program, to cover all undocumented immigrants. Doing so would ...
Commentary
COVID-19 tests come too late
Last week, the Biden administration announced that 67 million U.S. households ordered at-home COVID-19 tests through a government website in January. Ten million have yet to receive their tests — more than a month after the site launched. In many parts of the country, the omicron wave has already receded. Daily cases ...
Commentary
Stalled in D.C., the Single-Payer Fantasy Makes Its Way to Blue States
Despite the best efforts of progressives such as Senator Bernie Sanders (D., Vt.) and Representative Pramila Jayapal (D., Wash.), Medicare for All is off the table in Congress — for now, at least. But that doesn’t mean single-payer health care is dead. Like a zombie, the idea is being revived ...
Drug Pricing
Wayne Winegarden Discusses Prescription Drug Prices on Scripps National News
Watch PRI’s Wayne Winegarden, director of our Center for Medical Economics and Innovation, discuss efforts by the Federal Trade Commission to considering ordering large pharmacy benefits managers to study the competitive impact of contractual provisions, reimbursement adjustments, and other practices affecting drug prices on Scripps National News.
Health Care
Would Biden’s FDA Pick Make a Bad Situation Much Worse?
Would Biden’s FDA pick make a bad situation much worse? Listen to Dr. Henry Miller’s take on the Lars Larson Show.
Commentary
What science says about the future of COVID-19
There are possible ‘unknown unknowns’ that should concern us With pandemic fatigue becoming more intense, there is increasing speculation about when the SARS-CoV-2 virus, which causes COVID-19, might become “endemic” – a time when outbreaks will be more modest and manageable and we can “coexist” with the virus. A recent article in ...
Commentary
California Single-Payer Has Gone Up In Flames – For Now. Will Progressives Escape The Firestorm?
On January 31, the campaign for single-payer health care in California suffered its latest defeat. Progressive Democrats in the Assembly were unable to line up enough support for AB 1400, which would’ve launched a state takeover of private health insurance, Medicare, and Medi-Cal. So Assemblyman Ash Kalra, D-San Jose, the bill’s ...
Commentary
The FDA Needs Reform – Biden’s Nominee Is Not the Person to Do It
When President Joe Biden nominated former Obama-era Food and Drug Administration Commissioner Dr. Robert Califf to return to his old post, he made what was widely seen as a safe, if uninspired, choice. He easily sailed through a Dec. 14 Senate committee hearing to vet him. “[Califf] gushed about his love of high-quality ...
Don’t Dam the Telehealth Flood
To say that Americans are anxiously awaiting the end of the COVID-19 pandemic would be an understatement. But for patients who have enjoyed the ease of attending doctor’s appointments virtually, a return to the way things were pre-pandemic might be bittersweet. That’s because onerous restrictions on telemedicine, which lawmakers relaxed ...
High Healthcare Spending Doesn’t Bolster Case for Single-Payer
Does the United States spend too much on healthcare? A look at the lower levels of healthcare spending in peer countries like Canada and the United Kingdom would seem to indicate as much. But a closer look at those numbers reveals a far more complex story. Take the matter of ...
Plan to Expand Medi-Cal is a Costly Step Towards Single-Payer
It’s budget season in Sacramento. Governor Gavin Newsom’s spending proposal is the largest in the Golden State’s history. There’s no shortage of expensive and misguided policies in his budget. Chief among them is his push to expand Medi-Cal, the state’s Medicaid program, to cover all undocumented immigrants. Doing so would ...
COVID-19 tests come too late
Last week, the Biden administration announced that 67 million U.S. households ordered at-home COVID-19 tests through a government website in January. Ten million have yet to receive their tests — more than a month after the site launched. In many parts of the country, the omicron wave has already receded. Daily cases ...
Stalled in D.C., the Single-Payer Fantasy Makes Its Way to Blue States
Despite the best efforts of progressives such as Senator Bernie Sanders (D., Vt.) and Representative Pramila Jayapal (D., Wash.), Medicare for All is off the table in Congress — for now, at least. But that doesn’t mean single-payer health care is dead. Like a zombie, the idea is being revived ...
Wayne Winegarden Discusses Prescription Drug Prices on Scripps National News
Watch PRI’s Wayne Winegarden, director of our Center for Medical Economics and Innovation, discuss efforts by the Federal Trade Commission to considering ordering large pharmacy benefits managers to study the competitive impact of contractual provisions, reimbursement adjustments, and other practices affecting drug prices on Scripps National News.
Would Biden’s FDA Pick Make a Bad Situation Much Worse?
Would Biden’s FDA pick make a bad situation much worse? Listen to Dr. Henry Miller’s take on the Lars Larson Show.
What science says about the future of COVID-19
There are possible ‘unknown unknowns’ that should concern us With pandemic fatigue becoming more intense, there is increasing speculation about when the SARS-CoV-2 virus, which causes COVID-19, might become “endemic” – a time when outbreaks will be more modest and manageable and we can “coexist” with the virus. A recent article in ...
California Single-Payer Has Gone Up In Flames – For Now. Will Progressives Escape The Firestorm?
On January 31, the campaign for single-payer health care in California suffered its latest defeat. Progressive Democrats in the Assembly were unable to line up enough support for AB 1400, which would’ve launched a state takeover of private health insurance, Medicare, and Medi-Cal. So Assemblyman Ash Kalra, D-San Jose, the bill’s ...
The FDA Needs Reform – Biden’s Nominee Is Not the Person to Do It
When President Joe Biden nominated former Obama-era Food and Drug Administration Commissioner Dr. Robert Califf to return to his old post, he made what was widely seen as a safe, if uninspired, choice. He easily sailed through a Dec. 14 Senate committee hearing to vet him. “[Califf] gushed about his love of high-quality ...
